The supplementary research programme on the operation of the HFR, (hereinafter referred to as ‘the programme’), the objectives of which are set out in Annex I, is adopted for a period of four years, starting on 1 January 2012.
2012/709/Euratom: Council Decision of 13 November 2012 on the adoption of the 2012-2015 High Flux Reactor supplementary research programme to be implemented by the Joint Research Centre for the European Atomic Energy Community
2012/709/Euratom: Council Decision of 13 November 2012 on the adoption of the 2012-2015 High Flux Reactor supplementary research programme to be implemented by the Joint Research Centre for the European Atomic Energy Community
THE COUNCIL OF THE EUROPEAN UNION,
Having regard to the Treaty establishing the European Atomic Energy Community, and in particular Article 7 thereof,
Having regard to the proposal from the European Commission,
After consultation of the Scientific and Technical Committee(1),
Whereas:
Within the framework of the European Research Area, the high flux reactor at Petten (hereinafter ‘HFR’) has been, and continues to be for some time, an important means available to the Community to contribute to materials sciences and testing, to nuclear medicine and to reactor safety research in the field of nuclear energy.
The operation of the HFR has been supported by a series of supplementary research programmes the last of which, Council Decision 2009/410/Euratom of 25 May 2009 on the adoption of a supplementary research programme to be implemented by the Joint Research Centre for the European Atomic Energy Community(2), has expired on 31 December 2011. In order to ensure a continuity between the supplementary research programmes and a smooth operation of the 2012-2015 HFR supplementary research programme, this Decision should apply from 1 January 2012.
Given the continued need for the HFR as an irreplaceable infrastructure for Community research in the fields of improvement of safety of nuclear reactors, health including the development of medical isotopes to answer questions of medical research, nuclear fusion, fundamental research, training and waste management including the possibility to study the safety behaviour of nuclear fuels for reactor systems of interest to Europe, its operation should continue under this supplementary research programme until the end of 2015.
Due to their special interest in the continued operation of the HFR, the Netherlands, France and Belgium should, as indicated by them, finance this programme through financial contributions made to the general budget of the European Union by way of assigned revenue,
HAS ADOPTED THIS DECISION:
Article 1
Article 2
The costs for the execution of the programme, estimated at EUR 31 400 000, shall be financed entirely out of contributions from the Netherlands, France and Belgium. The breakdown of this amount is set out in Annex II. This contribution shall be considered as assigned revenue in accordance with Article 18(2) of Council Regulation (EC, Euratom) No 1605/2002(3).
Article 3
1.
The Commission shall be in charge of the management of the programme. To this end, it shall call upon the services of the Joint Research Centre.
2.
The Board of Governors of the Joint Research Centre shall be kept informed of the implementation of the programme.
Article 4
The Commission shall submit to the European Parliament and to the Council, a mid-term report and a final report on the implementation of this Decision.